Conserved CXCR4 usage and enhanced replicative capacity of HIV-2/287, an isolate highly pathogenic in Macaca nemestrina

AIDS

Volumn 15, Issue 18, 2001, Pages 2349-2357

  Rey Cuille, M A ^a   Hu, S L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Animal models; Coreceptor; HIV 2; Pathogenesis; Primate; Reverse transcription; Virus cell interaction

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; GAG PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 2; LONG TERMINAL REPEAT; MACACA; MONONUCLEAR CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; RESTRICTION MAPPING; REVERSE TRANSCRIPTION; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ANIMALS; ANTIGENS, CD4; DISEASE MODELS, ANIMAL; HIV INFECTIONS; HIV-2; HUMANS; LEUKOCYTES, MONONUCLEAR; MACACA NEMESTRINA; RECEPTORS, CXCR4; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 0035824772     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200112070-00002     Document Type: Article

References (50)

1. Promiscuous use of CC and CXC chemokine receptors in cell-to-cell fusion mediated by a human immunodeficiency virus type 2 envelope protein
2. Identification of a major co-receptor for primary isolates of HIV-1
3. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
4. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
5. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor
6. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry
7. Usage of the coreceptors CCR-5, CCR-3, and CXCR-4 by primary and cell line-adapted human immunodeficiency virus type 2
8. HIV-1 subtype and second-receptor use
9. Replicative capacity of HIV-2, like HIV-1, correlates with severity of immunodeficiency
10. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals
11. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
12. Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression
13. Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression
14. Consistent viral evolutionary changes associated with the progression of human immunodeficlency virus type 1 infection
15. CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain
16. CD4-independent binding of SIV gp120 to rhesus CCR5
17. Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: Comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo
18. An AIDS-like condition induced in baboons by HIV-2
19. HIV-2 macaque model for HIV infection and pathogenesis
20. Differential replication and pathogenic effects of HIV-1 and HIV-2 in Macaca nemestrina
21. Derivation and characterization of a highly pathogenic isolate of human immunodeficiency virus type 2 that causes rapid CD4+ cell depletion in Macaca nemestrina
22. Early postinfection antiviral treatment reduces viral load and prevents CD4+ cell decline in HIV type 2-infected macaques
23. Characterization of an HIV-2-related virus with a smaller sized extracellular envelope glycoprotein
24. Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage
25. Pharmacophore identification of a chemokine receptor (CXCR4) antagonist, T22 ([Tyr(5,12),Lys7]-polyphemusin II), which specifically blocks T cell-line-tropic HIV-1 infection
26. HIV-2 EHO isolate has a divergent envelope gene and induces single cell killing by apoptosis
27. The CC-chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosaminoglycans and also activates a signal transduction pathway that enhances viral infectivity
28. A simple method of estimating fifty percent endpoints
29. HIV-1 entry and reverse transcription in macrophages
30. Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses
31. Co-receptor usage of BOB/ GPR15 in addition to CCR5 has No significant effect on replication of simian immunodeficiency virus In vivo
32. Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 disease
33. Coreceptor usage of human immunodeficiency virus type 2 primary isolates and biological clones is broad and does not correlate with their syncytium-inducing capacities
34. Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry
35. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: A comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac
36. Simian immunodeficiency virus variants with differential T-cell and macrophage tropism use CCR5 and an unidentified cofactor expressed in CEMx174 cells for efficient entry
37. Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239
38. Characterization of a novel simian immunodeficiency virus (SIV) from L'Hoest monkeys (Cercopithecus I'hoesti): Implications for the origins of SIVmnd and other primate lentiviruses
39. Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression
40. Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVMne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication, cytopathicity, or CCR-5 coreceptor recognition
41. The biology and immunopathology of simian immunodeficiency virus infection
42. The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection
43. Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors
44. Acute infection of Macaca nemestrina by human immunodeficiency virus type 1
45. Restriction of HIV-1 (subtype B) replication at the entry step in rhesus macaque cells
46. In vitro HIV-1 infection in Macaca nemestrina PBMCs is blocked ata step beyond reverse transcription
47. Infection of Macaca nemestrina by human immunodeficiency virus type-1
48. Serial in vivo passage of HIV-1 infection in Macaca nemestrina
49. Infection of Macaca nemestrina neonates with HIV-1 via different routes of inoculation
50. Enhanced replication of HIV-1 in vivo in pigtailed macaques (Macaca nemestrina)